Hattersheim, Germany

Klaus Bock

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Bock. Retrieved from https://idiyas.com/inventor/klaus-bock-d6lthq75

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Bock: Innovator in Bile Acid Derivatives

Introduction

Klaus Bock is a notable inventor based in Hattersheim, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of modified bile acids.

Latest Patents

Klaus Bock holds a patent for a "Modified bile acids process for their preparation and their use." This invention relates to linker-modified bile acid derivatives, which are therapeutically active and suitable as drugs, especially as hypolipidemics. The patent outlines a process for the preparation of these compounds, which are defined by specific radicals and parameters.

Career Highlights

Klaus Bock has had a distinguished career, working with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has focused on the development of innovative therapeutic agents that can improve health outcomes.

Collaborations

Throughout his career, Klaus has collaborated with esteemed colleagues such as Gunther Wess and Alfons Ehnsen. These partnerships have contributed to the advancement of research in the field of bile acid derivatives.

Conclusion

Klaus Bock's innovative work in the area of modified bile acids has the potential to impact the pharmaceutical industry significantly. His contributions continue to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…